Stock listing
KRX:048530 iNtRON Biotechnology, Inc. (인트론바이오) 주가
Follow iNtRON Biotechnology, Inc. into a list and get an email when it puts out news.
Share price · KRX:048530
₩2,485.00 KRW +60.00 (+2.5%)
Close on Nov 20, 2026
- Day range
- ₩2,380.00 – ₩2,515.00 KRWNov 20, 2026
- Volume
- 136,094 sharesNov 20, 2026
- Market cap
- ₩76.77B KRWAt the close on Nov 20, 2026 · price × 30.89M shares outstanding
- 52-week range
- ₩2,250.00 – ₩7,010.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩624.9M KRWMedian day 75,143 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:048530 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩2,485.00 | +60.00 | +2.5% | ₩2,500.00 | ₩2,515.00 | ₩2,380.00 | 136,094 | |
| ₩2,425.00 | -50.00 | -2.0% | ₩2,470.00 | ₩2,520.00 | ₩2,405.00 | 106,896 | |
| ₩2,475.00 | +55.00 | +2.3% | ₩2,370.00 | ₩2,495.00 | ₩2,370.00 | 43,782 | |
| ₩2,420.00 | -145.00 | -5.7% | ₩2,570.00 | ₩2,625.00 | ₩2,420.00 | 110,597 | |
| ₩2,565.00 | 0.00 | 0.0% | ₩2,570.00 | ₩2,600.00 | ₩2,490.00 | 56,568 | |
| ₩2,565.00 | -65.00 | -2.5% | ₩2,625.00 | ₩2,625.00 | ₩2,510.00 | 101,178 | |
| ₩2,630.00 | +50.00 | +1.9% | ₩2,530.00 | ₩2,645.00 | ₩2,490.00 | 84,207 | |
| ₩2,580.00 | +25.00 | +1.0% | ₩2,590.00 | ₩2,675.00 | ₩2,535.00 | 34,333 | |
| ₩2,555.00 | +40.00 | +1.6% | ₩2,560.00 | ₩2,600.00 | ₩2,405.00 | 55,390 | |
| ₩2,515.00 | -145.00 | -5.5% | ₩2,540.00 | ₩2,700.00 | ₩2,500.00 | 94,365 | |
| ₩2,660.00 | -65.00 | -2.4% | ₩2,725.00 | ₩2,770.00 | ₩2,590.00 | 87,553 | |
| ₩2,725.00 | +25.00 | +0.9% | ₩2,700.00 | ₩2,750.00 | ₩2,615.00 | 64,730 | |
| ₩2,700.00 | -95.00 | -3.4% | ₩2,800.00 | ₩2,800.00 | ₩2,655.00 | 88,915 | |
| ₩2,795.00 | +5.00 | +0.2% | ₩2,790.00 | ₩2,840.00 | ₩2,720.00 | 71,814 | |
| ₩2,790.00 | -85.00 | -3.0% | ₩2,885.00 | ₩2,900.00 | ₩2,735.00 | 133,014 | |
| ₩2,875.00 | -170.00 | -5.6% | ₩3,045.00 | ₩3,055.00 | ₩2,850.00 | 117,839 | |
| ₩3,045.00 | -5.00 | -0.2% | ₩3,070.00 | ₩3,105.00 | ₩3,000.00 | 138,825 | |
| ₩3,050.00 | 0.00 | 0.0% | ₩3,115.00 | ₩3,280.00 | ₩2,950.00 | 303,007 | |
| ₩3,050.00 | -15.00 | -0.5% | ₩3,010.00 | ₩3,140.00 | ₩3,000.00 | 222,342 | |
| ₩3,065.00 | -90.00 | -2.9% | ₩3,100.00 | ₩3,250.00 | ₩3,000.00 | 445,063 | |
| ₩3,155.00 | +235.00 | +8.0% | ₩2,920.00 | ₩3,400.00 | ₩2,905.00 | 1,558,831 | |
| ₩2,920.00 | -80.00 | -2.7% | ₩2,980.00 | ₩2,990.00 | ₩2,860.00 | 303,178 | |
| ₩3,000.00 | +190.00 | +6.8% | ₩2,855.00 | ₩3,500.00 | ₩2,825.00 | 5,729,848 | |
| ₩2,810.00 | +25.00 | +0.9% | ₩2,785.00 | ₩2,875.00 | ₩2,725.00 | 40,862 | |
| ₩2,785.00 | +95.00 | +3.5% | ₩2,665.00 | ₩2,820.00 | ₩2,665.00 | 88,011 | |
| ₩2,690.00 | -95.00 | -3.4% | ₩2,760.00 | ₩2,770.00 | ₩2,630.00 | 114,362 | |
| ₩2,785.00 | +65.00 | +2.4% | ₩2,770.00 | ₩2,945.00 | ₩2,730.00 | 229,215 | |
| ₩2,720.00 | -80.00 | -2.9% | ₩2,805.00 | ₩2,805.00 | ₩2,670.00 | 85,414 | |
| ₩2,800.00 | -45.00 | -1.6% | ₩2,810.00 | ₩2,855.00 | ₩2,760.00 | 59,778 | |
| ₩2,845.00 | -40.00 | -1.4% | ₩2,860.00 | ₩2,865.00 | ₩2,755.00 | 97,571 | |
| ₩2,885.00 | +50.00 | +1.8% | ₩2,870.00 | ₩2,995.00 | ₩2,815.00 | 286,805 | |
| ₩2,835.00 | +30.00 | +1.1% | ₩2,845.00 | ₩2,905.00 | ₩2,775.00 | 87,563 | |
| ₩2,805.00 | -85.00 | -2.9% | ₩2,890.00 | ₩2,905.00 | ₩2,805.00 | 44,005 | |
| ₩2,890.00 | +65.00 | +2.3% | ₩2,825.00 | ₩2,925.00 | ₩2,805.00 | 42,857 | |
| ₩2,825.00 | -5.00 | -0.2% | ₩2,930.00 | ₩2,930.00 | ₩2,800.00 | 39,695 | |
| ₩2,830.00 | -65.00 | -2.2% | ₩2,895.00 | ₩2,895.00 | ₩2,800.00 | 39,238 | |
| ₩2,895.00 | +80.00 | +2.8% | ₩2,900.00 | ₩2,930.00 | ₩2,860.00 | 57,551 | |
| ₩2,815.00 | -30.00 | -1.1% | ₩2,890.00 | ₩2,900.00 | ₩2,780.00 | 33,357 | |
| ₩2,845.00 | -45.00 | -1.6% | ₩2,960.00 | ₩2,960.00 | ₩2,830.00 | 34,223 | |
| ₩2,890.00 | +60.00 | +2.1% | ₩2,860.00 | ₩2,950.00 | ₩2,730.00 | 58,110 | |
| ₩2,830.00 | -120.00 | -4.1% | ₩2,990.00 | ₩2,990.00 | ₩2,820.00 | 62,440 | |
| ₩2,950.00 | +50.00 | +1.7% | ₩2,900.00 | ₩2,980.00 | ₩2,895.00 | 71,176 | |
| ₩2,900.00 | +40.00 | +1.4% | ₩2,890.00 | ₩2,935.00 | ₩2,820.00 | 54,496 | |
| ₩2,860.00 | -40.00 | -1.4% | ₩2,900.00 | ₩2,975.00 | ₩2,835.00 | 60,728 | |
| ₩2,900.00 | +205.00 | +7.6% | ₩2,740.00 | ₩2,940.00 | ₩2,665.00 | 142,568 | |
| ₩2,695.00 | +20.00 | +0.7% | ₩2,685.00 | ₩2,720.00 | ₩2,615.00 | 23,989 | |
| ₩2,675.00 | -90.00 | -3.3% | ₩2,780.00 | ₩2,780.00 | ₩2,625.00 | 60,239 | |
| ₩2,765.00 | -20.00 | -0.7% | ₩2,785.00 | ₩2,805.00 | ₩2,685.00 | 54,067 | |
| ₩2,785.00 | -85.00 | -3.0% | ₩2,870.00 | ₩2,940.00 | ₩2,765.00 | 52,794 | |
| ₩2,870.00 | -5.00 | -0.2% | ₩2,875.00 | ₩2,950.00 | ₩2,810.00 | 37,929 | |
| ₩2,875.00 | +65.00 | +2.3% | ₩2,810.00 | ₩2,890.00 | ₩2,740.00 | 78,471 | |
| ₩2,810.00 | 0.00 | 0.0% | ₩2,920.00 | ₩3,050.00 | ₩2,760.00 | 121,889 | |
| ₩2,810.00 | -40.00 | -1.4% | ₩2,850.00 | ₩2,855.00 | ₩2,790.00 | 47,714 | |
| ₩2,850.00 | +50.00 | +1.8% | ₩2,800.00 | ₩2,875.00 | ₩2,770.00 | 45,348 | |
| ₩2,800.00 | -45.00 | -1.6% | ₩2,845.00 | ₩2,845.00 | ₩2,770.00 | 60,715 | |
| ₩2,845.00 | +50.00 | +1.8% | ₩2,815.00 | ₩2,885.00 | ₩2,755.00 | 47,881 | |
| ₩2,795.00 | -20.00 | -0.7% | ₩2,810.00 | ₩2,820.00 | ₩2,770.00 | 26,990 | |
| ₩2,815.00 | -25.00 | -0.9% | ₩2,840.00 | ₩2,845.00 | ₩2,735.00 | 53,456 | |
| ₩2,840.00 | -10.00 | -0.4% | ₩2,855.00 | ₩2,855.00 | ₩2,710.00 | 79,281 | |
| ₩2,850.00 | +105.00 | +3.8% | ₩2,825.00 | ₩2,910.00 | ₩2,775.00 | 244,278 | |
| ₩2,745.00 | -55.00 | -2.0% | ₩2,795.00 | ₩2,800.00 | ₩2,645.00 | 101,238 | |
| ₩2,800.00 | +150.00 | +5.7% | ₩2,725.00 | ₩2,800.00 | ₩2,645.00 | 126,340 |
Splits
2 splits since 2013 · KRX:048530 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 13-for-10 | Split |
- Ticker
- KRX:048530
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Latest news
iNtRON Biotechnology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 4 in all · newest Aug 26, 2025 · oldest 2025
Valuation
EV/sales 5.8× against a median of 8.5×: 3rd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩41.98B KRW
- P/E
- Loss
- EV/sales
- 5.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.2×
- Gross margin
- 49.9%
- Operating margin
- −109.2%
- Net margin
- −142.6%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| iNtRON Biotechnology, Inc. · KRX:048530 | US$57.38M | US$31.38M | n/a | 5.8× | n/a | 1.2× | −142.6% | 0.0× | n/a |
| Rani Therapeutics Holdings, Inc. · NASDAQ:RANI | US$58.99M | US$16.85M | n/a | 2.6× | n/a | 1.7× | −493.0% | 0.1× | 2.21 |
| HeXun Biosciences Co Ltd · TPEX:6986 | US$57.20M | US$32.05M | 16.2× | 3.4× | 6.5× | 1.8× | 37.7% | 0.0× | n/a |
| Tenax Therapeutics, Inc. · NASDAQ:TENX | US$56.92M | −US$56.78M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.35 |
| Kazia Therapeutics Ltd · NASDAQ:KZIA | US$56.22M | US$10.36M | n/a | 373× | n/a | 1.8× | n/a | 0.0× | 2.31 |
| OKYO Pharma Limited · NASDAQ:OKYO | US$56.15M | US$35.56M | n/a | n/a | n/a | 4.5× | n/a | 0.0× | 1.02 |
| Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704 | US$55.77M | US$51.65M | n/a | 9.1× | n/a | 2.5× | −43.0% | 0.3× | n/a |
| EyeGene, Inc. · KRX:185490 | US$55.57M | US$26.66M | n/a | 8.0× | n/a | 1.5× | −391.5% | 0.0× | n/a |
| Cognition Therapeutics, Inc. · NASDAQ:CGTX | US$55.37M | US$25.10M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | 2.28 |
| AB Science SA · EURONEXT:AB | US$55.19M | US$50.54M | n/a | 39.2× | n/a | n/a | −132.6% | n/a | n/a |
| Azora Therapeutics, Inc. · NASDAQ:AZR | US$55.00M | US$33.00M | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 |
| Median of the others | US$55.96M | US$29.36M | 16.2× | 8.5× | 6.5× | 1.8× | −132.6% | 0.0× | 1.78 |
Team and board
| Officer | Role |
|---|---|
| Kyung Won | Kevin / CEO, Vice President / |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 17, 2026 | −0.6% |
| Q1 2026 | May 14, 2026 · Before open | +0.1% |
| Q4 2025 | Mar 9, 2026 · Before open | −15.0% |
| Q3 2025 | Nov 12, 2025 · Before open | +4.1% |
| Q2 2025 | Aug 29, 2025 | −0.8% |
| Q1 2025 | May 15, 2025 · Before open | −0.9% |
| Q4 2024 | Mar 11, 2025 · After close | +1.2% |
| Q3 2024 | Nov 12, 2024 · After close | −2.8% |
| Q2 2024 | Aug 14, 2024 · After close | +3.5% |
| Q1 2024 | May 14, 2024 · After close | −0.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 13, 2024 · After close | +2.8% |
| Q3 2023 | Nov 14, 2023 · After close | +10.8% |
| Q2 2023 | Aug 11, 2023 · After close | −1.6% |
| Q1 2023 | May 15, 2023 · After close | −2.2% |
| Q4 2022 | Feb 17, 2023 · Before open | +0.6% |
| Q3 2022 | Nov 14, 2022 · Before open | −1.4% |
| Q2 2022 | Aug 16, 2022 · Before open | −5.0% |
| Q1 2022 | May 13, 2022 · Before open | +2.2% |
| Q4 2021 | Feb 9, 2022 · Before open | +3.4% |
| Q3 2021 | Nov 12, 2021 · Before open | +2.8% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.74B | 6.42B | 9.59B | 14.0B | 29.3B | 45.4B | 8.35B | 20.6B | 11.0B | 10.2B |
| Cost of revenue | 2.64B | 2.68B | 3.74B | 4.35B | 7.54B | 18.9B | 4.55B | 5.42B | 5.93B | 5.19B |
| Gross profit | 3.10B | 3.74B | 5.84B | 9.66B | 21.8B | 26.5B | 3.80B | 15.2B | 5.03B | 5.03B |
| Research and development | 4.65B | 3.48B | 3.17B | 3.31B | 3.55B | 3.49B | 2.25B | 3.66B | 3.50B | 3.11B |
| Selling, general and administrative | 1.67B | 4.69B | 5.22B | 7.13B | 7.44B | 6.55B | 5.24B | 6.04B | 5.17B | 5.13B |
| Operating income | -7.90B | -5.24B | -9.04B | -1.47B | 10.1B | 15.9B | -4.25B | 5.17B | -6.37B | -1.17B |
| Depreciation and amortization | 1.95B | 1.77B | 1.67B | 1.57B | 1.54B | 1.57B | 1.42B | 940.4M | 896.1M | 672.3M |
| EBITDA | -5.96B | -3.46B | -7.36B | 93.5M | 11.6B | 17.4B | -2.82B | 6.11B | -5.48B | -496.9M |
| Interest expense | 89.9M | 23.4M | 2.92B | 3.51B | 1.64B | 1.18B | 1.22B | 0 | 0 | 0 |
| Income before tax | -9.03B | -3.01B | -10.8B | 8.32B | 10.6B | 17.1B | -1.91B | 7.31B | -9.08B | -709.6M |
| Income tax | 2.61B | 846.8M | 2.10B | 1.27B | -1.40B | -345.1M | -630.5M | |||
| Net income | -8.96B | -2.59B | -9.70B | 5.71B | 9.73B | 14.9B | -3.19B | 8.71B | -8.73B | -610.4M |
| Earnings per share, basic | -290.00 | -81.03 | -292.10 | 172.09 | 288.42 | 454.94 | -106.43 | 290.89 | -291.68 | -20.38 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 27.7B | 34.4B | 41.0B | 2.27M | 2.93M | 59.9B | 53.3B | 21.1B | 15.7B | 19.3B |
| Short-term investments | 14.1B | 15.5B | 16.2B | 21.5B | 8.33B | 6.24B | 3.04B | 42.0M | 3.31B | 4.13B |
| Receivables | 817.1M | 913.0M | 1.99B | 3.78B | 9.75B | 11.8B | 2.95B | 5.06B | 5.69B | 5.03B |
| Inventory | 841.9M | 1.12B | 1.01B | 800.4M | 1.00B | 1.53B | 1.35B | 1.46B | 1.17B | 1.10B |
| Current assets | 43.8B | 52.2B | 61.0B | 113.9B | 125.5B | 81.3B | 75.3B | 40.2B | 31.1B | 34.8B |
| Property, plant and equipment | 22.7B | 15.0B | 13.8B | 12.0B | 7.55B | 7.59B | 7.92B | 7.75B | ||
| Total assets | 74.3B | 86.4B | 98.6B | 141.0B | 153.4B | 100.5B | 89.0B | 54.8B | 45.6B | 59.6B |
| Accounts payable | 60.6M | 418.0K | 97.0M | 561.0M | 206.7M | 263.6M | 161.4M | 314.8M | 217.4M | |
| Current liabilities | 4.09B | 1.34B | 786.0M | 32.2B | 33.3B | 12.7B | 4.68B | 14.2B | 13.8B | 8.11B |
| Long-term debt | 861.4M | 0 | 0 | 16.1B | 0 | 13.8B | 225.0M | 552.1M | 1.55B | |
| Total debt | 174.3M | 14.8B | 3.22B | 3.55B | 2.55B | |||||
| Total liabilities | 4.45B | 2.60B | 1.88B | 34.8B | 52.0B | 15.2B | 24.1B | 15.7B | 15.4B | 10.5B |
| Shareholders' equity | 69.9B | 83.8B | 96.7B | 106.2B | 101.3B | 85.4B | 65.0B | 39.1B | 30.2B | 49.1B |
| Shares outstanding | 30.9M | 32.0M | 33.2M | 33.2M | 33.7M | 32.9M | 29.9M | 29.9M | 29.9M | 29.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.21B | -138.5M | 3.12B | 5.98B | 16.5B | 7.13B | -812.5M | 4.20B | -5.47B | -4.64B |
| Capital spending | -2.47B | -1.19B | -9.55B | -2.23B | -3.05B | -4.85B | -300.4M | -550.6M | -973.9M | -4.72B |
| Free cash flow | -7.68B | -1.32B | -6.43B | 3.36B | 13.0B | 1.06B | -3.68B | 3.65B | -6.44B | -9.37B |
| Cash from investing | 3.07B | 52.2B | -46.2B | -41.3B | 2.36B | -4.52B | -1.26B | -1.96B | -7.55B | |
| Cash from financing | -9.82B | -40.2B | -9.19B | 39.7B | -2.07B | 37.3B | 1.98B | 4.45B | 22.0B | |
| Dividends paid | -3.20B | -3.32B | ||||||||
| Share buybacks | -1.72B | -7.19B | -8.99B | 20.0B | 56.6M | 21.6B | ||||
| Change in cash | -6.70B | -6.63B | 15.2B | -49.4B | 15.2B | 6.51B | 32.0B | 4.99B | -3.11B | 9.85B |
Cap table
Built by 6ix from iNtRON Biotechnology, Inc.’s releases
- Common shares
- 30,891,758
- Fully diluted
- 30,891,758
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 30,891,758 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 30,891,758 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kyung Won | Kevin / CEO, Vice President / · Since at least Aug 26, 2025 |
Log in to ask 6ix AI your own questions about iNtRON Biotechnology, Inc.